pharmaceuticals

FAS abolished agreed prices for “Bartizar” medicinal drug
The FAS Russia established that the drug manufacturer submitted false information on the prices of raw materials supplies and set an excessive euro exchange rate in its estimates
more
FAS position on compiling the list of vital and essential drugs
The FAS Russia considered a petition of “Johnson & Johnson” Ltd. on the need to re-file a proposal to include medicinal drugs in the list of vital and essential drugs for 2018
more
FAS proposals on indexing prices for the life-saving and essential medicinal drugs in the lower price segment
Due to numerous reports in mass media FAS would like to inform that in November 2015 the Federal Antimonopoly Service (FAS Russia) indeed submitted a proposal to the Government of the Russian Federation to support domestic pharmaceutical manufacturers in the part of one-time indexing of prices for the drugs included in the list of life-saving and essential medicinal drugs with the registered price for up to 50 RUB.
more
FAS will give approvals for regional mark-ups for life-saving and essential medicines
On 1 March 2016 the Federal Antimonopoly Service (FAS Russia) shall be assigned the powers to approve regional maximum wholesale and retail mark-ups to ex-works prices for life-saving and essential medicines. The Prime Minister Dmitry Medvedev signed a relevant Decree (1) on 3 February 2016.
more

Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide